The safety of our associates and patients globally are our primary concern.
Novartis aims to be carbon neutral by 2025, and plastic and water neutral in all our operations and supply chain by 2030. In Singapore, we are making good progress.
Through collaborative partnerships of both public and private organizations, we can deepen access to healthcare and deliver better outcomes in Asia and around the world.
Creating business models that can strengthen public health systems in Asia for the long-term.
This site is intended for an audience in Singapore.